Micrograph of prostate cancer with Gleason score 6 (3+3) (photo credit: Diagnostic Pathology 11/Jennifer Gordetsky and Jonathan Epstein) The Health Ministry in Jerusalem has just published data on ...

In 2010, a 61-year-old man diagnosed with low-risk, early-stage (Gleason 6) prostate cancer enrolled in a clinical trial designed to compare outcomes of active surveillance vs definitive treatment.

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Prostate cancer is common among men dying of other causes ... Fewer men requiring a biopsy Fewer men diagnosed with Gleason 6 (GG1) Diagnosing nearly all the men with Gleason ≥7 (GG2) (compared to ...

A precursor of vitamin K may help slow down prostate cancer progression, a recent study conducted in mouse models of suggests ...

1) OR: Odds Ratio derived from logistic regression considering as cases patients whose biopsy Gleason score was lower than the prostatectomy Gleason score and as controls everybody else ...

[6] However, improved grayscale resolution ... stiff area that corresponds to the nodule. Biopsy confirmed Gleason grade 7 prostate cancer. Elastography images are courtesy of Dennis Cochlin ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

Medically reviewed by Amelia MacIntyre, DO Approximately 1 in 8 people with a prostate are diagnosed with prostate cancer ...

The following is dedicated to our health care workers who looked after me on my prostate journey.

Recently, a new personalized risk estimator was developed that more accurately predicts metastasis and prostate cancer–specific death than National Comprehensive Cancer Network (NCCN) risk groups. 6 ...